These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37648114)

  • 21. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative description of thermodynamic and kinetic properties of the platelet factor 4/heparin bonds.
    Nguyen TH; Greinacher A; Delcea M
    Nanoscale; 2015 Jun; 7(22):10130-9. PubMed ID: 25981976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
    Blank M; Cines DB; Arepally G; Eldor A; Afek A; Shoenfeld Y
    Clin Exp Immunol; 1997 May; 108(2):333-9. PubMed ID: 9158107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.
    Kowalska MA; Krishnaswamy S; Rauova L; Zhai L; Hayes V; Amirikian K; Esko JD; Bougie DW; Aster RH; Cines DB; Poncz M
    Blood; 2011 Sep; 118(10):2882-8. PubMed ID: 21772054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complexes of platelet factor 4 and heparin activate Toll-like receptor 4.
    Prechel MM; Walenga JM
    J Thromb Haemost; 2015 Apr; 13(4):665-70. PubMed ID: 25604035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
    Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
    Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating anti-PF4 disorders: An overview.
    Warkentin TE
    Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic basis of heparin-induced thrombocytopenia.
    Poncz M
    Semin Thorac Cardiovasc Surg; 2005; 17(1):73-9. PubMed ID: 16104364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.
    Lubenow N; Hinz P; Thomaschewski S; Lietz T; Vogler M; Ladwig A; Jünger M; Nauck M; Schellong S; Wander K; Engel G; Ekkernkamp A; Greinacher A
    Blood; 2010 Mar; 115(9):1797-803. PubMed ID: 19965682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4.
    Kreimann M; Brandt S; Krauel K; Block S; Helm CA; Weitschies W; Greinacher A; Delcea M
    Blood; 2014 Oct; 124(15):2442-9. PubMed ID: 25150299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid.
    Newman PM; Swanson RL; Chong BH
    Thromb Haemost; 1998 Aug; 80(2):292-7. PubMed ID: 9716155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-induced thrombocytopenia: frequency and pathogenesis.
    Greinacher A
    Pathophysiol Haemost Thromb; 2006; 35(1-2):37-45. PubMed ID: 16855345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular architecture and platelet-activating properties of small immune complexes assembled on heparin and platelet factor 4.
    Yang Y; Du Y; Ivanov D; Niu C; Clare R; Smith JW; Nazy I; Kaltashov IA
    Commun Biol; 2024 Mar; 7(1):308. PubMed ID: 38467823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.
    Cines DB; Yarovoi SV; Zaitsev SV; Lebedeva T; Rauova L; Poncz M; Arepally GM; Khandelwal S; Stepanova V; Rux AH; Cuker A; Guo C; Ocariza LM; Travers RJ; Smith SA; Kim H; Morrissey JH; Conway EM
    Blood Adv; 2016 Nov; 1(1):62-74. PubMed ID: 29296696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia.
    Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A
    Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
    Krauel K; Hackbarth C; Fürll B; Greinacher A
    Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
    Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
    Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
    Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
    J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.